Titan Biotech Complete Financial Statements
TITANBIO • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Titan Biotech (TITANBIO).
Downloads include all available records across all periods.
For market performance, see the
TITANBIO stock price today
.
Profitability Ratios
Net Profit Margin
14.29%
2025 data
EBITDA Margin
19.64%
2025 data
Operating Margin
17.00%
2025 data
Return on Assets
4.57%
2025 data
Return on Equity
5.23%
2025 data
Balance Sheet Ratios
Current Ratio
19.75
2025 data
Debt to Equity
1.14
2025 data
Equity Ratio
87.43%
2025 data
Asset Turnover
0.32
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+40.0%
Year-over-Year
Net Profit Growth
+14.3%
Year-over-Year
EBITDA Growth
+37.5%
Year-over-Year
Expense Growth
+40.6%
Year-over-Year
Assets Growth
+11.5%
Year-over-Year
Equity Growth
+14.2%
Year-over-Year
Liabilities Growth
+11.5%
Year-over-Year
Operating Cash Flow Growth
-4.8%
Year-over-Year
Investing Cash Flow Growth
+50.0%
Year-over-Year
Financing Cash Flow Growth
-166.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Jun 2016 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56 | 37 | 47 | 40 | 40 | 44 | 40 | 44 | 37 | 35 | 46 | 43 | 33 | 35 | 31 | 41 | 36 | 42 | 37 | 33 | 20 | 40 | 35 | 19 | 18 | 22 | 19 | 17 | 15 | 16 | 15 | 16 | 15 | 13 | 15 | 14 | 12 | 12 |
| Expenses | 45 | 31 | 38 | 32 | 33 | 35 | 33 | 35 | 30 | 27 | 35 | 31 | 26 | 27 | 26 | 30 | 29 | 27 | 28 | 22 | 17 | 21 | 25 | 16 | 15 | 18 | 16 | 15 | 13 | 14 | 13 | 14 | 13 | 11 | 13 | 12 | 11 | 11 |
| EBITDA | 11 | 6 | 10 | 8 | 8 | 9 | 6 | 9 | 7 | 8 | 11 | 11 | 8 | 8 | 4 | 11 | 7 | 15 | 9 | 11 | 3 | 19 | 10 | 3 | 2 | 5 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Operating Profit Margin % | 17.00% | 13.00% | 19.00% | 19.00% | 18.00% | 19.00% | 13.00% | 20.00% | 19.00% | 23.00% | 23.00% | 25.00% | 23.00% | 23.00% | 14.00% | 26.00% | 19.00% | 35.00% | 24.00% | 33.00% | 16.00% | 46.00% | 28.00% | 14.00% | 11.00% | 21.00% | 17.00% | 15.00% | 9.00% | 14.00% | 15.00% | 13.00% | 11.00% | 12.00% | 13.00% | 7.00% | 9.00% | 13.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 5 | 8 | 7 | 6 | 8 | 5 | 8 | 6 | 7 | 10 | 11 | 7 | 8 | 4 | 10 | 6 | 14 | 8 | 10 | 2 | 18 | 9 | 2 | 1 | 4 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 2 | 0 | 0 | 2 | 2 | 4 | 2 | 3 | 0 | 4 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 8 | 4 | 7 | 7 | 5 | 6 | 4 | 7 | 5 | 6 | 7 | 9 | 5 | 8 | 3 | 8 | 4 | 10 | 6 | 8 | 2 | 13 | 7 | 2 | 1 | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Earnings Per Share (₹) | 9.40 | 4.90 | 8.30 | 8.10 | 6.05 | 7.74 | 5.31 | 7.89 | 6.07 | 7.47 | 8.68 | 11.04 | 6.03 | 9.08 | 3.95 | 7.74 | 4.55 | 10.56 | 6.33 | 8.72 | 2.33 | 15.42 | 8.02 | 1.72 | 0.80 | 2.37 | 2.13 | 1.41 | 1.05 | 1.12 | 1.10 | 0.51 | 1.14 | 0.79 | 1.00 | 0.72 | 0.58 | 0.37 |
Related Pages for Titan Biotech
Additional stock information and data for TITANBIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 175 | 157 | 135 | 108 | 101 | 76 | 65 | 57 | 52 | 40 | 34 |
| Current Assets | 79 | 73 | 68 | 64 | 59 | 44 | 35 | 29 | 30 | 24 | 21 |
| Fixed Assets | 57 | 52 | 36 | 35 | 34 | 31 | 29 | 14 | 13 | 11 | 11 |
| Capital Work in Progress | 2 | 3 | 13 | 4 | 0 | 0 | 0 | 13 | 9 | 5 | 1 |
| Investments | 33 | 28 | 15 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 74 | 70 | 65 | 67 | 45 | 36 | 30 | 30 | 24 | 22 |
| LIABILITIES | |||||||||||
| Total Liabilities | 175 | 157 | 135 | 108 | 101 | 76 | 65 | 57 | 52 | 40 | 34 |
| Current Liabilities | 4 | 4 | 4 | 5 | 9 | 14 | 15 | 20 | 16 | 5 | 3 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 153 | 134 | 110 | 86 | 73 | 42 | 34 | 26 | 24 | 23 | 21 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 145 | 125 | 102 | 78 | 61 | 31 | 24 | 17 | 15 | 14 | 13 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 20 | 21 | 21 | 22 | 19 | 6 | 6 | 2 | 0 | 5 | -2 |
| Investing Activities | -10 | -20 | -21 | -16 | -5 | -2 | -4 | -6 | -8 | -5 | -3 |
| Financing Activities | -8 | -3 | -2 | -4 | -11 | -4 | 0 | 0 | 9 | 2 | 3 |
| Net Cash Flow | 2 | -2 | -2 | 2 | 4 | 0 | 1 | -3 | 1 | 2 | -2 |